<VariationArchive RecordType="classified" VariationID="30351" VariationName="NM_004813.4(PEX16):c.984del (p.Ile330fs)" VariationType="Deletion" Accession="VCV000030351" Version="2" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-04-25" DateCreated="2019-09-16" MostRecentSubmission="2019-09-16">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="39307" VariationID="30351">
      <GeneList>
        <Gene Symbol="PEX16" FullName="peroxisomal biogenesis factor 16" GeneID="9409" HGNC_ID="HGNC:8857" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11p11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="45909663" stop="45918822" display_start="45909663" display_stop="45918822" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="45931219" stop="45939673" display_start="45931219" display_stop="45939673" Strand="-" />
          </Location>
          <OMIM>603360</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_004813.4(PEX16):c.984del (p.Ile330fs)</Name>
      <CanonicalSPDI>NC_000011.10:45910280:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11p11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="45910281" stop="45910281" display_start="45910281" display_stop="45910281" variantLength="1" positionVCF="45910280" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="45931832" stop="45931832" display_start="45931832" display_stop="45931832" variantLength="1" positionVCF="45931831" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>I330fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.45910281del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.45910281del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.45931832del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.45931832del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008460.1" sequenceAccession="NG_008460" sequenceVersion="1" change="g.12843del">
            <Expression>NG_008460.1:g.12843del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_004813.4" sequenceAccession="NM_004813" sequenceVersion="4" change="c.984del" MANESelect="true">
            <Expression>NM_004813.4:c.984del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_004804.2" sequenceAccession="NP_004804" sequenceVersion="2" change="p.Ile330fs">
            <Expression>NP_004804.2:p.Ile330fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_057174.3" sequenceAccession="NM_057174" sequenceVersion="3" change="c.953-104del">
            <Expression>NM_057174.3:c.953-104del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="603360.0003" DB="OMIM" />
        <XRef Type="rs" ID="1590793006" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="ClinGen" Type="public">ClinGen staff contributed the HGVS expression for this variant.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_004813.4(PEX16):c.984del (p.Ile330fs) AND Peroxisome biogenesis disorder 8B" Accession="RCV000023293" Version="3">
        <ClassifiedConditionList TraitSetID="8960">
          <ClassifiedCondition DB="MedGen" ID="C3553960">Peroxisome biogenesis disorder 8B</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2010-09-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2010-09-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2019-09-16" MostRecentSubmission="2019-09-16">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">20647552</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="8960" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17439" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Peroxisome biogenesis disorder 8B</ElementValue>
                <XRef ID="MONDO:0013943" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PBD8B</ElementValue>
                <XRef Type="MIM" ID="614877" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">The overlapping phenotypes of neonatal adrenoleukodystrophy (NALD) and infantile Refsum disease (IRD) represent the milder manifestations of the Zellweger syndrome spectrum (ZSS) of peroxisome biogenesis disorders. The clinical course of patients with the NALD and IRD presentation is variable and may include developmental delay, hypotonia, liver dysfunction, sensorineural hearing loss, retinal dystrophy, and visual impairment. Children with the NALD presentation may reach their teens, and those with the IRD presentation may reach adulthood (summary by Waterham and Ebberink, 2012).
For a complete phenotypic description and a discussion of genetic heterogeneity of PBD(NALD/IRD), see 601539.
Individuals with mutations in the PEX16 gene have cells of complementation group 9 (CG9, equivalent to CGD). For information on the history of PBD complementation groups, see 214100.</Attribute>
                <XRef Type="MIM" ID="614877" DB="OMIM" />
              </AttributeSet>
              <XRef ID="44" DB="Orphanet" />
              <XRef ID="C3553960" DB="MedGen" />
              <XRef ID="MONDO:0013943" DB="MONDO" />
              <XRef Type="MIM" ID="614877" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="49840" SubmissionDate="2019-09-10" DateLastUpdated="2019-09-16" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="603360.0003_PEROXISOME BIOGENESIS DISORDER 8B" title="PEX16, 1-BP DEL, 984G_PEROXISOME BIOGENESIS DISORDER 8B" />
        <ClinVarAccession Accession="SCV000044584" DateUpdated="2019-09-16" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2010-09-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In 2 sibs, born of consanguineous Turkish parents, with a peroxisomal biogenesis disorder (PBD8B; 614877), Ebberink et al. (2010) identified a homozygous 1-bp deletion (984delG) in exon 11a of the PEX16 gene, resulting in a frameshift and premature protein truncation. Exon 11b was unaffected. Both patients presented between age 1 and 2 years with delayed walking and frequent falls after normal initial development. The disorder was progressive, characterized by lower limb spasticity and ataxia resulting in wheelchair-dependence in the first decade. Studies of skin fibroblasts showed that peroxisomes were markedly enlarged in size and reduced in number compared to controls. However, biochemical studies showed only mild abnormalities, such as increased very-long-chain fatty acids (VLCFA), increased bile acid intermediates, and increased branched chain fatty acids (only found in 1 sib). Expression of wildtype PEX16 restored the number and size of peroxisomes in patient fibroblasts to normal. Ebberink et al. (2010) emphasized that even though PEX16 is involved in peroxisomal membrane assembly, PEX16 defects can present with a relatively mild phenotype showing import-competent peroxisomes in fibroblasts.</Attribute>
              <Citation>
                <ID Source="PubMed">20647552</ID>
              </Citation>
              <XRef DB="OMIM" ID="614877" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="PEX16" />
          </GeneList>
          <Name>PEX16, 1-BP DEL, 984G</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 984G</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="603360.0003" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">PEROXISOME BIOGENESIS DISORDER 8B</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="49840" TraitType="Disease" MappingType="Name" MappingValue="PEROXISOME BIOGENESIS DISORDER 8B" MappingRef="Preferred">
        <MedGen CUI="C3553960" Name="Peroxisome biogenesis disorder 8B" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

